[Long-term results conventional and eversion carotid endarterectomy].

Objective: To analyze immediate and long-term results of conventional and eversion carotid endarterectomy (CEA) within a multicenter registry.

Material And Methods: This retrospective, multi-center, comparative study included 375 patients who underwent CEA between February 1, 2018 and February 1, 2022. Depending on the type of operation, the sample was stratified into the eversion CEA (group 1, =218) and conventional CEA with plasty of the reconstruction area with a diepoxy-treated xenopericardium patch (group 2, =157).

[Results of carotid endarterectomy in the acutest period of ischemic stroke].

Objective: Analysis of the results of carotid endarterectomy (CEE) in the acute period of ischemic stroke (IS).

Material And Methods: This retrospective study included 128 patients (mean age 65.2±4.

[Some psychiatric and neurological aspects of the asymptomatic and mild course of COVID-19].

Objective: To study neurological and mental disorders associated with the inapparent and mild course of COVID-19.

Material And Methods: The study included 50 patients (mean age 35.2±11.

[Modern strategies of protection of hypoxic-ischemic brain damage].

Nowadays, there are two complementary approaches to treatment of patients with ischemic stroke: reperfusion and neuroprotection. The main purpose of neuroprotection is to intervene ischemic cascade at every stage of the pathological process and thus avoid the death of nerve cells and expand the therapeutic window for reperfusion therapy. The use of drugs with neurotrophic, antioxidant and neuroregenerative effects is pathogenically explained at all stages of post stroke rehabilitation.

[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].

The aim of the study was to determine the quantitative content and correlation between metabolites in the core ischemic zone, the ischemic penumbra and the intact tissue of the opposite hemisphere in the acute stage of ischemic stroke using MR-spectroscopy. We studied 72 patients, including 37 patients (the main group) treated with the antioxidant mexidol (2-ethyl-6-methyl-3-hydroxypiridine succinate) in addition to standard therapy and 35 patients who received standard therapy only. The severity of stroke was assessed using the NIHSS.